MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-13-2023
Sientra Operating Income 2011-2026 | SIEN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Sientra
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -46.4 M | -47.4 M | -54.9 M | -79.8 M | -62.9 M | -40 M | -38.5 M | -5.78 M | -18.2 M | -23.4 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -5.78 M | -79.8 M | -41.7 M |
Quarterly Operating Income Sientra
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.4 M | -7.11 M | - | - | -12.6 M | -15.9 M | -16.1 M | - | -11.7 M | -9.16 M | -11.8 M | - | -9.53 M | -9.24 M | -27 M | - | -21.5 M | -37 M | -25.9 M | - | -19.6 M | -16.9 M | -18.9 M | - | -13.9 M | -20.2 M | -11.4 M | - | -9.77 M | -10.2 M | -11.9 M | - | -5.57 M | -2.12 M | -2.63 M | - | -753 K | -1.2 M | -1.38 M | - | -6.23 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -753 K | -37 M | -12.5 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 13.93 | 5.85 % | $ 2.09 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 32.5 | -8.14 % | $ 1.5 B | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 268.7 | - | $ 7.58 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 6.39 | 0.79 % | $ 459 M |  Israel |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.54 | -0.84 % | $ 123 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 14.55 | -1.42 % | $ 393 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.47 | -1.11 % | $ 167 M |  France |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 39.77 | 0.53 % | $ 5.93 K | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 75.15 | - | $ 111 B | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
9.66 M | $ 23.15 | -5.16 % | $ 196 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 46.06 | - | $ 1.43 B | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-12.4 M | $ 9.95 | 2.16 % | $ 284 M | USA |
 |
LivaNova PLC
LIVN
|
129 M | $ 69.05 | 1.02 % | $ 3.75 B |  Britain |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
85.4 M | $ 13.98 | -1.55 % | $ 904 M | Israel |
 |
IRadimed Corporation
IRMD
|
22 M | $ 99.09 | -1.92 % | $ 1.26 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-50 M | $ 79.67 | 6.28 % | $ 2.24 B |  Costa-rica |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.57 | -0.11 % | $ 122 M | USA |
 |
Pulmonx Corporation
LUNG
|
-57.7 M | $ 1.51 | 2.03 % | $ 59.1 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 91.88 | - | $ 12.4 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.85 | -1.6 % | $ 1.12 M | USA |
 |
Myomo
MYO
|
-10.7 M | $ 0.65 | -5.24 % | $ 4.58 M | USA |
 |
Medtronic PLC
MDT
|
5.96 B | $ 96.75 | - | $ 124 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 11.53 | -1.96 % | $ 888 M | USA |